Skip to content
Close
SEARCH

PERSPECTIVES

Strategy and execution insights from life science experts

Bridging strategy and execution

The life science industry is on the verge of unprecedented change, driven by scientific breakthroughs, technological convergence, and shifting healthcare models. Life science leaders face essential new choices for how to adapt and evolve. Successful choices require full attention to the big picture, with an eye to the layers of complexity beneath it.

As advisors to senior executives across the global life science ecosystem, we have distilled hands-on experience and learnings from hundreds of projects into practical insights. Explore our perspectives and cases written for executives within Research & Development, Commercial & Medical, and CEOs & Boards.

Cases and perspectives

Building the engine for omnichannel at scale
Case Building the engine for omnichannel at scale
CaseBuilding the engine for omnichannel at scale

Orchestrating a global transformation in customer engagement

Read More
How do you substantiate the value of a Lab-of-the-Future investment?
Case How do you substantiate the value of a Lab-of-the-Future investment?
CaseHow do you substantiate the value of a Lab-of-the-Future investment?

Justifying the investments in a Lab of the Future requires bridging the gaps between scientist expectations and the CFO lens

Read More
Designing a clinical operating model built for the future
Case Designing a clinical operating model built for the future
CaseDesigning a clinical operating model built for the futureMaking clinical governance usable when the portfolio grows faster than the modelRead More
More with less through new global commercial operating model
Case More with less through new global commercial operating model
CaseMore with less through new global commercial operating model

Achieving more with less through new commercial operating model

Read More
Growth strategy for immunology portfolio
Case Growth strategy for immunology portfolio
CaseGrowth strategy for immunology portfolio

TA strategy and repositioning of immunology portfolio

Read More
Creating a global content hub to accelerate global-to-local execution
Case Creating a global content hub to accelerate global-to-local execution
CaseCreating a global content hub to accelerate global-to-local executionTurning an underused central hub into the option markets pick over local agenciesRead More
From AI ambition to operational reality in R&D
Case From AI ambition to operational reality in R&D
CaseFrom AI ambition to operational reality in R&D

Baselining AI capabilities across R&D as foundation for shared direction

Read More
When everything has to happen at once
Case When everything has to happen at once
CaseWhen everything has to happen at once

Organisational development plan to manage rapid scaling of biotech company

Read More
Growth strategy for established brand facing new market entrants
Case Growth strategy for established brand facing new market entrants
CaseGrowth strategy for established brand facing new market entrants

Reigniting growth of an established brand through data-driven methodology

Read More
Building launch readiness beyond the playbook
Case Building launch readiness beyond the playbook
CaseBuilding launch readiness beyond the playbookAssessing readiness through market understanding and execution confidence, not template completionRead More
From ecosystem presence to R&D pipeline impact
Case From ecosystem presence to R&D pipeline impact
CaseFrom ecosystem presence to R&D pipeline impactConverting hub presence into durable access to science, talent, and early-stage assetsRead More
Improving MASH patient care pathways
Case Improving MASH patient care pathways
CaseImproving MASH patient care pathwaysLocating where a fragmented care pathway breaks down, and where intervention shifts outcomesRead More
Driving Medical Excellence across fragmented Medical Affairs organisations
Case Driving Medical Excellence across fragmented Medical Affairs organisations
CaseDriving Medical Excellence across fragmented Medical Affairs organisationsCoordinating scientific engagement across global, regional, and affiliate teams without adding activityRead More
Setting up a PMO to roll-out a global clinical operating model
Case Setting up a PMO to roll-out a global clinical operating model
CaseSetting up a PMO to roll-out a global clinical operating modelRolling out a new operating model globally without disrupting day-to-day deliveryRead More
Do you have a robust strategy?
Case Do you have a robust strategy?
CaseDo you have a robust strategy?

Recognising plausible scenarios for the future to enable robust strategic choices to navigate the uncertainty of future market, regulatory and technology developments

Read More
Designing the Lab of the Future
Case Designing the Lab of the Future
CaseDesigning the Lab of the Future

Designing SAR cycle workflows and technology platforms to unlock the scientific and financial value in a Lab of the Future

Read More
CRA Productivity Improvement
Case CRA Productivity Improvement
CaseCRA Productivity Improvement

Improving CRA productivity to accelerate time-to-market and improve frontline operational efficiency

Read More
Show more

Don't miss future perspectives

You’ll hear from us when we publish new insights about the life science industry. Enter your email to receive them straight to your inbox.

Who we are

Our team of life science strategists blends international experience and backgrounds from MDs, PhDs, and top-tier strategy consulting. We engage with a structured and collaborative approach to develop practical solutions to complex problems. Meet our team of experienced life science consultants.

Daniel Schmidt
TOUCH
Daniel Schmidt PartnerDaniel works with life science executives to design strategies, operating models, and transformation programs. He brings both functional depth and board-level perspectives, helping senior leaders navigate complexity and make clear choices. He formerly led the life science practice at Deloitte Denmark.
Daniel Schmidt Partner
Jonas Karlsen
TOUCH
Jonas Karlsen PartnerJonas is a life science strategist supporting executives drive progress across the value chain. He is an expert in bridging strategy and execution via global operating model design and transformation rooted in strategic objectives. He engages with structured top-down thinking and a pragmatic and collaborative approach to mobilise organizations and make things happen.
Jonas Karlsen Partner
Jens Rommer
TOUCH
Jens Rommer PartnerJens is a seasoned strategy advisor with 30 years of experience in management consulting. Former Head of Monitor Deloitte Denmark, he brings deep expertise in shaping corporate agendas, TA strategies, operating model design, digital and AI value creation, and M&A for leading global corporations.
Jens Rommer Partner
Florian Preis
TOUCH
Florian Preis PrincipalFlorian is a life science strategist supporting pharma and biotech leaders shape therapeutic area and launch performance. He is an expert in translating global strategic direction into market-level execution, and in the operating models that make it hold. He works hypothesis-led and close to the client, bringing a point of view early and sharpening it through rigorous analysis.
Florian Preis Principal
Johannes Bæk Christensen
TOUCH
Johannes Bæk Christensen Project LeaderJohannes has 7+ years of experience in strategy consulting and has strong expertise in TA strategy, organisational transformations, operating model design, and commercial launch planning.  Johannes holds an M.Sc. in Economics from the University of Copenhagen.
Johannes Bæk Christensen Project Leader
Mette Brøgger-Mikkelsen, MD
TOUCH
Mette Brøgger-Mikkelsen, MD Project LeaderMette blends medical expertise with strategic experience as a medical doctor and former strategy consultant. Before joining Biobridge Partners, she worked at Bain & Company and LEO Innovation Lab. She focuses on cross-functional engagement in medical and commercial functions in pharma.
Mette Brøgger-Mikkelsen, MD Project Leader
Alfred Bukh Johannesen
TOUCH
Alfred Bukh Johannesen Senior ConsultantAlfred is a seasoned life science strategy consultant with a background from Monitor Deloitte and 3+ years’ experience helping clients articulate and assess strategies, develop strategic options, and translate strategic intent into actionable plans.
Alfred Bukh Johannesen Senior Consultant
Amadou Benavent
TOUCH
Amadou Benavent Senior ConsultantAmadou brings a cross-disciplinary background in Biotechnology and Business Administration. He has experience in strategic projects spanning the full pharmaceutical value chain, from early research to development and commercial strategy.
Amadou Benavent Senior Consultant
Daniell I. F. Skourup
TOUCH
Daniell I. F. Skourup Marketing LeadDaniell leads marketing at Biobridge Partners, helping shape the firm’s positioning, narrative, and go-to-market execution across brand and thought leadership. He brings a background in design and concept development, including experience as a product designer on the health app SELF and 3 years leading marketing at BASE life science.
Daniell I. F. Skourup Marketing Lead
Caroline Clausen
TOUCH
Caroline Clausen AnalystCaroline brings a strong international background and a passion for life science and its potential for impact. She is pursuing a B.Sc. in International Business at CBS, with a growing focus on strategy, market access, and business development in the life sciences sector.
Caroline Clausen Analyst
Anton Oliver Klapp
TOUCH
Anton Oliver Klapp AnalystAnton is a life science strategy analyst with a cross-disciplinary background in molecular medicine and business administration. He has hands-on experience in gene and cell therapy research and focuses on translating scientific innovation into real-world impact through strategic insight.
Anton Oliver Klapp Analyst
Bertram Toft Kristiansen
TOUCH
Bertram Toft Kristiansen AnalystBertram brings prior experience in life science and a strong interest in strategy and business development. He is pursuing a B.Sc. in International Business at CBS, with a focus on market entry and growth topics within the life sciences sector.
Bertram Toft Kristiansen Analyst
Nicolai Hesdorf
TOUCH
Nicolai Hesdorf Chair of the Board of DirectorsNicolai is a seasoned management consultant with over 20 years of experience working with C-suite executives at Danish C25 companies. He has held several leadership roles, including Senior Partner and Nordic Lead for Monitor Deloitte and Managing Director of Accenture Denmark.
Nicolai Hesdorf Chair of the Board of Directors
Camilla Harder Hartvig
TOUCH
Camilla Harder Hartvig Board MemberCamilla brings nearly 30 years of global pharmaceutical leadership, holding senior roles at AstraZeneca, Novartis, Allergan, Alexion, Theramex, and most recently EVP, President, International at Ascendis. Her career spans global commercial and executive leadership roles.
Camilla Harder Hartvig Board Member
Alexander Peitersen
TOUCH
Alexander Peitersen Board MemberAlexander has 25 years of experience as an international strategy and communications advisor, supporting C-suite leaders at global biopharmaceutical companies on life science branding, digital strategy, and commercialisation. He is founder of the strategic advisory firm &Now, and co-founder of the communications firm REPUTATION.
Alexander Peitersen Board Member
Show more